Clinical Trials Browser

Interventional × mirdametinib × Breast × Clear all

NCT05054374 2025-05-23

A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer

Phase 1/2 Completed

6 enrolled 4 charts

Breast Neoplasms

NCT00147550 2013-09-13

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

Phase 1/2 Terminated

BreastDermatologicGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Melanoma